Meridiem Investment Management Ltd. Has $315.07 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Meridiem Investment Management Ltd. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 641,307 shares of the medical equipment provider’s stock after selling 78,608 shares during the quarter. Intuitive Surgical comprises about 5.6% of Meridiem Investment Management Ltd.’s investment portfolio, making the stock its 7th biggest position. Meridiem Investment Management Ltd. owned about 0.18% of Intuitive Surgical worth $315,071,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ISRG. Capital Research Global Investors bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at approximately $374,390,000. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after buying an additional 493,126 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in Intuitive Surgical by 51.2% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 893,341 shares of the medical equipment provider’s stock worth $356,524,000 after buying an additional 302,382 shares during the period. Strategic Financial Concepts LLC increased its position in Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after acquiring an additional 265,461 shares during the last quarter. Finally, GQG Partners LLC bought a new position in shares of Intuitive Surgical during the first quarter valued at approximately $99,523,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,655,048.26. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,655,048.26. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 53,120 shares of company stock worth $25,528,753. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock traded up $47.42 during midday trading on Friday, reaching $521.15. The stock had a trading volume of 4,059,157 shares, compared to its average volume of 1,478,565. The firm has a fifty day simple moving average of $483.85 and a two-hundred day simple moving average of $437.79. The stock has a market cap of $184.85 billion, a PE ratio of 94.07, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $523.34.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter in the previous year, the company posted $1.18 earnings per share. The company’s revenue was up 14.5% compared to the same quarter last year. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently issued reports on ISRG. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday. Finally, JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $503.75.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.